Publicaciones en colaboración con investigadores/as de Universitat de València (13)

2024

  1. Novel biomarkers and psoriasis associated cardiovascular risk

    Archives of Dermatological Research, Vol. 316, Núm. 5

2022

  1. Neutrophil-to-lymphocyte ratio as a cardiovascular risk biomarker in psoriasis: A comprehensive review

    JEADV Clinical Practice, Vol. 1, Núm. 4, pp. 397-406

  2. SEA 2022 Standards for Global Control of Cardiovascular Risk

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 3, pp. 130-179

  3. Safety and effectiveness of sucroferric oxyhydroxide in Spanish patients on dialysis: sub-analysis of the VERIFIE study

    Nefrologia, Vol. 42, Núm. 5, pp. 594-606

2019

  1. Standards for global cardiovascular risk management arteriosclerosis

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, pp. 1-43

2017

  1. Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in internal medicine and neurology departments of Spain

    Revista de Neurologia, Vol. 65, Núm. 8, pp. 361-367

2015

  1. Pro12Ala polymorphism of the PPARγ2 gene interacts with a Mediterranean diet to prevent telomere shortening in the PREDIMED-NAVARRA randomized trial

    Circulation: Cardiovascular Genetics, Vol. 8, Núm. 1, pp. 91-99

2014

  1. Longitudinal association of telomere length and obesity indices in an intervention study with a Mediterranean diet: The PREDIMED-NAVARRA trial

    International Journal of Obesity, Vol. 38, Núm. 2, pp. 177-182

  2. MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy

    Stem Cells, Vol. 32, Núm. 2, pp. 447-461

2012

  1. Adipose stromal vascular fraction improves cardiac function in chronic myocardial infarction through differentiation and paracrine activity

    Cell Transplantation, Vol. 21, Núm. 5, pp. 1023-1037

2010

  1. Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension

    Journal of Hypertension, Vol. 28, Núm. 11, pp. 2219-2226

  2. Topical issues in venous thromboembolism

    Drugs, Vol. 70, Núm. SUPPL. 2, pp. 11-18

2007

  1. A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension

    Journal of Hypertension, Vol. 25, Núm. 8, pp. 1620-1626